Low levels of CD33 expression on native T cells likely accounts for this observation (online supplemental figure S7).24 Importantly, tumor cells that did not express the antigen targeted by specified memAb did not activate Fabrack T cells, again, suggesting the specificity of memAb binding to an antigen and the meditope peptide. The gene discussed is CD33; the disease is neoplasm.